Executives On The Move: I-Mab Brings On An Amgen Communications Exec And SciTech Picks A CMO, Along With A Promotion At Urovant Sciences
I-Mab Biopharma, a Chinese firm focusing on biologics for cancer and immune diseases, brings on an Amgen exec as global head, corporate communications, and SciTech Development, with its proprietary nano-delivery system, adds a new CMO. Plus, urologic therapies company Urovant Sciences promotes a director to CEO.
You may also be interested in...
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Executives On The Move: New Choices For Finance Spots At Merz Aesthetics, Spruce Biosciences And Lodo Therapeutics
New CFOs are announced at three companies: MerzPharma Group’s Merz Aesthetics; Spruce Biosciences, a firm focusing on treatments for rare endocrine disorders; and Lodo Therapeutics, which is developing novel therapeutics for undruggable targets.
Sol Barer, founder and former CEO of Celgene, has been appointed chair of Cerecor; he is already chair of Teva, Centrexion Therapeutics and NexImmune. Also, PTC Therapeutics announces promotions and ProBioGen gets a new CEO.